<bill session="115" type="s" number="2451" updated="2023-01-11T13:40:24Z">
  <state datetime="2018-02-26">REFERRED</state>
  <status>
    <introduced datetime="2018-02-26"/>
  </status>
  <introduced datetime="2018-02-26"/>
  <titles>
    <title type="display">Protection from Overprescribing Act</title>
    <title type="official" as="introduced">A bill to require the Secretary of Health and Human Services to consider State analysis and sharing of prescription drug monitoring program data in determining prescription drug monitoring program grants to States.</title>
    <title type="short" as="introduced">Protection from Overprescribing Act</title>
  </titles>
  <sponsor bioguide_id="C001075"/>
  <cosponsors/>
  <actions>
    <action datetime="2018-02-26">
      <text>Introduced in Senate</text>
    </action>
    <action datetime="2018-02-26" state="REFERRED">
      <text>Read twice and referred to the Committee on Health, Education, Labor, and Pensions.</text>
    </action>
  </actions>
  <committees>
    <committee code="SSHR" name="Senate Health, Education, Labor, and Pensions" subcommittee="" activity="Referral"/>
  </committees>
  <relatedbills/>
  <subjects>
    <term name="Health"/>
  </subjects>
  <amendments/>
  <summary date="2019-03-18T13:34:08Z" status="Introduced in Senate">Protection from Overprescribing Act

This bill requires the Department of Health and Human Services to consider when awarding a grant to a state to support the state's prescription drug monitoring program whether the state's program provides reports to law enforcement agencies, licensing boards, and other agencies describing any prescribers who repeatedly fall outside of expected norms or standard practices.</summary>
</bill>
